TrialJournal for immunotherapy of cancer2023

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.

Axel Stenmark Tullberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.